Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 14,364 | 18,880 | 18,803 | 17,949 | 15,539 |
| Cost of Goods | 8,245 | 10,683 | 10,328 | 9,831 | 8,498 |
| Gross Profit | 6,119 | 8,197 | 8,475 | 8,118 | 7,041 |
| Operating Expenses | 5,266 | 5,395 | 4,939 | 5,221 | 4,006 |
| Operating Income | 1,098 | 3,485 | 3,864 | 3,729 | 3,533 |
| Interest Expense | 78 | 255 | 251 | 217 | 122 |
| Other Income | -11,673 | -12,749 | -2,766 | -1,518 | -3,505 |
| Pre-tax Income | -10,653 | -9,519 | 848 | 1,993 | -94 |
| Income Tax | 239 | 1,517 | 232 | -1,333 | -801 |
| Net Income Continuous | -10,892 | -11,036 | 616 | 3,326 | 706 |
| Net Income | $-10,892 | $-11,036 | $616 | $3,326 | $706 |
| EPS Basic Total Ops | -0.01 | -0.01 | 0.00 | 0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.01 | -0.01 | 0.00 | 0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Before Non-Recurring Items | -0.01 | 0.00 | 0.00 | N/A | N/A |
| EBITDA(a) | $1,591 | $4,042 | $4,426 | $4,229 | $3,883 |